Your browser doesn't support javascript.
loading
Complementary and alternative medicine for treating epilepsy in China: A systematic review.
Zhao, Chenyang; Lu, Lu; Liu, Wenyu; Zhou, Dong; Wu, Xintong.
Afiliação
  • Zhao C; Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Lu L; Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Liu W; Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Zhou D; Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Wu X; Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Acta Neurol Scand ; 146(6): 775-785, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36082744
ABSTRACT
There are about 10 million people with epilepsy (PWE) in China. In addition to therapies approved by the National Medical Products Administration, the use of complementary and alternative medicine (CAM) is prevalent in Chines PWE. These CAM therapies mainly comprise traditional Chinese medicine herbs (TCMHs), acupuncture, and music. A retrospective literature search was performed to summarize the updates of CAM in China in the past ten years, and sixty-two papers were finally included. In this following review, we listed the animal and clinical studies to summarize the antiepileptic mechanisms and clinical efficacy of CAM in Chines PWE. The main mechanisms of TCMHs and acupuncture included regulation of neurotransmitters and receptors, voltage-gated ion channels modulation, expression of apoptosis-related genes, antioxidant response, and anti-inflammation. Although there were enormous clinical studies on them, the current available clinical trials were small, short-term, heterogeneous, and had a high risk of bias. With regard to music, a few studies conducted by Chinese scholars suggested that it was beneficial for PWE as an add-on therapy, which was consistent with the results of foreign studies. Further randomized clinical trials in large populations are required to prove the effectiveness and safety of CAM.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapias Complementares / Epilepsia Tipo de estudo: Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Acta Neurol Scand Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapias Complementares / Epilepsia Tipo de estudo: Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Acta Neurol Scand Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China